Stockscreener 앱 받기
701.23
2.45%
16.80
Lilly Eli Co 주식(LLY)의 최신 뉴스
Eli Lilly & Co’s CFO Makes a Bold Move with New Stock Purchase! - TipRanks
Eli Lilly and Co Options Spot-On: On August 15th, 243.55K Contracts Were Traded, With 573.94K Open Interest - 富途牛牛
Eli Lilly & Co. hikes UK weight-loss drug’s price amid pressure from Trump - WISH-TV
Eli Lilly: Bet Against Insiders (NYSE:LLY) - Seeking Alpha
Why Novo Nordisk Flew Almost 3% Higher on Friday - The Motley Fool
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst - inkl
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI - Reuters
Texas Lawsuit Filed Against Eli Lilly (LLY) Amid New Cardio Collaboration - simplywall.st
Jim Cramer Says Eli Lilly Stock (LLY) Has Been ‘Laid to Waste’ - TipRanks
Eli Lilly and Co: Steve Mandel's Strategic Exit with a -3.94% Portfolio Impact - Yahoo Finance
UK patients rush for obesity jab before Eli Lilly raises price 170% to appease Donald Trump - Financial Times
Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US - sg.finance.yahoo.com
Eli Lilly raises UK price of Mounjaro, a look at salary of CEO David A. Ricks - NationalWorld
Eli Lilly takes slim bet with bloated UK pricing - Breakingviews
Eli Lilly to hike UK price of weight-loss drug Mounjaro - Proactive financial news
Eli Lilly Strikes $1.3 Billion Deal With Superluminal To Develop AI-Driven Obesity Drugs - inkl
Jim Cramer Says He is “Very Upset” With Eli Lilly - Insider Monkey
Mounjaro weight-loss drug price to almost triple in UK after Trump complaint - The Independent
Director Makes a Bold Move with Major Stock Purchase in Eli Lilly & Co! - TipRanks
Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands - The Guardian
Friday Five – Summer of the scythe, Padcev's perioperative promise, Lilly links with Superliminal for GPCR goals…and more - FirstWord Pharma
Deal Watch: Lilly Teams With GPCR-Focused Superluminal In Cardiometabolic Disease - insights.citeline.com
Texas AG Accuses Lilly Of Offering Providers Illegal Incentives - InkFreeNews.com
Superluminal joins a $1.3B deal with series A backer Lilly - BioWorld MedTech
Alvarez buys Eli Lilly shares worth $500k By Investing.com - Investing.com India
Cause Marketing: Eli Lilly Brings Free Mammograms and Health Education to WNBA All-Star Weekend - Event Marketer
Lilly says it will raise drug prices in Europe, responding to Trump threats - BioPharma Dive
Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines - Fast Company
Eli Lilly and Company (LLY): “Wall Street Was Really Wrong,” Says Jim Cramer - Insider Monkey
Eli Lilly hikes weight-loss drug prices in Canada, Britain after pressure from Trump - The Globe and Mail
Eli Lilly Strikes $1.3B Superluminal Deal to Tackle Obesity and Cardiometabolic Diseases - USA Herald
Eli Lilly To Hike Mounjaro Prices By A Whopping 170% In UK: Retail Expects Stock To See Smooth Rally Till $720 - Stocktwits
Eli Lilly seeks more GPCR weight loss drugs in $1.3bn research deal - Pharmaceutical Technology
Eli Lilly Completes Phase 3 Study on Orforglipron for Obesity Treatment - TipRanks
Lilly invests in Boston biotech for $1.3B obesity drug deal - The Business Journals
Eli Lilly To Plug $1.3B Into Obesity-Focused Medicine Biz - Law360
Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S. - statnews.com
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs - CNBC
Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines - Reuters
Eli Lilly to raise UK price of weight-loss drug Mounjaro by 170% - Business Standard
Lilly raises UK obesity shot price as Trump pressures pharma - Yahoo Finance
Pharmaceutical Industry Compliance Risks: Evaluating Eli Lilly's Legal Exposure and Its Implications for Big Pharma and Investors - AInvest
Why Is Eli Lilly Stock Climbing Thursday?Eli Lilly (NYSE:LLY) - Benzinga
Eli Lilly hikes UK price of blockbuster weight loss drug Mounjaro by up to 170% - Yahoo Life UK
Lilly to hike UK price of Mounjaro weight-loss drug by 170% - Reuters
Lilly hikes UK obesity shot price as Trump pressures drugmakers - The Detroit News
Texas sues Eli Lilly for allegedly bribing medical providers to prescribe its drugs - Investorsobserver
Lilly Hikes UK Obesity Shot Price as Trump Pressures Drugmakers - Bloomberg.com
Eli Lilly to hike UK price of Mounjaro weight-loss, diabetes medicines by 170% - TradingView
Eli Lilly raises UK price of weight loss drug Mounjaroreport - Investing.com
Eli Lilly raises UK price of obesity drug by up to 170% after Trump ‘freeloading’ gripe - Financial Times
Lilly signs up to $1.3 billion deal with Superluminal for obesity drugs - StreetInsider
Statement: America’s leading role in biopharmaceutical innovation - Eli Lilly and Company
1.10%
자본화:
|
볼륨(24시간):